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Abstract: The laccase-catalyzed oxidation of a
series of substituted 4-hydroxy-chalcones has been
investigated. The main isolated dimeric products
were, as expected, racemic mixtures of trans-2,3-
dihydrobenzofuran derivatives, always co-eluted
with an additional isomeric dimer with an open
structure. The two enantiomers, as well as the co-
eluted dimeric isomer could be isolated by semi-
preparative HPLC with a chiral column and were
fully characterized.
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The 2,3-dihydrobenzofuran (DHB, (A), Figure 1) skel-
eton is widely present in a large number of bioactive
natural products, isolated mainly from plants but also
from fungi, that belong to different classes, such as
alkaloids, isoflavonoids, lignans and neolignans. These
compounds have been the targets of a substantial
number of synthetic studies, as the preparation of
substituted DHB is not an easy task.[1]
Moreover, the DHB skeleton is also recurrent in the
complex polymeric structure of lignin, where it has
been classified as the so-called β-5 unit.[2] In Nature
lignin is obtained by the polymerization of hydrox-
yphenyl-propenol precursors by action of several
oxidative enzymes, among which the blue oxidases
laccases, which catalyze the oxidation of phenolic
compounds at the expense of molecular oxygen that is
reduced to water,[3] play a significant role.
In previous investigations we have shown that
laccases can be exploited for the preparative scale
oxidation of substituted vinyl phenols[4] and polyhy-
droxy-stilbenes,[5] the main isolated products being the
corresponding DHB derivatives (Scheme 1, part A).
In the most recent example, the same protocol
proved to be very efficient for the synthesis of
substituted (E)-2,3-diaryl-5-styryl-trans-2,3-dihydro-
benzofurans based on the oxidative (homo)-coupling
of (E)-4-styrylphenols (isolated yield up to 74%)
(Scheme 1, part B).[6] In this way, considering their
structural analogies to previously reported allosteric
modulators,[7] a library of DHB-based potential allos-
teric activators of the Heat shock protein 90 (Hsp90)
was easily prepared and tested in vitro for the potential
stimulatory action of these compounds on the ATPase
activity of the molecular chaperone Hsp90. Two of
those sixteen DHB derivatives showed an appreciable
activator activity.
To extend the scope of this straightforward syn-
thetic approach to the DHB skeleton, we focused our
attention to a new series of compounds, namely the
chalcones (i. e., (B), Figure 1), with the aim to enrich
the range of substituents located on the DHB moiety
Figure 1. Structure of compounds (A) and (B)
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(Scheme 1, part C). In the following the results that
have been obtained will be presented and discussed.
Chalcones is a generic name, coined a long time
ago by Kostanecki and Tambor,[8] to indicate a generic
chemical framework (1,3-diphenylprop-2-en-1-one)
that is widely spread in the plant kingdom. They are
open chain precursors for the biosynthesis of flavo-
noids and isoflavonoids. Their simple synthesis and
chemical manipulation as well as the biological
activities showed by several members of this family
make the chalcone scaffold an interesting template in
medicinal chemistry for drug discovery, as documented
in several recent reviews.[9]
The classical chemical synthesis of chalcones is
based on the Claisen-Schmidt condensation of suitably
substituted benzaldehydes and acetophenones, per-
formed either under basic[10] or acid[11] catalysis. In our
hands and confirming early literature reports,[12] due to
the presence of the phenolic substituent, the acid
catalysis proved to be more efficient in most of the
cases and, specifically, the protocol was exploited for
the synthesis of the 4-hydroxy compounds 2a–2d
(Scheme 2).
Despite the fact that chalcones and specifically
hydroxyl-chalcones are well-known antioxidants,[12,13]
to our surprise there are only very few reports
specifically devoted to the study of the outcome of
oxidation reactions of these compounds[14] and, to the
best of our knowledge, none of them describes the
oxidation of 4-hydroxy chalcones (like our substrates
1a–1c and 2a–2d).
The non-substituted 4-hydroxy chalcone 1a was
initially considered, and its laccase-catalyzed oxidation
was investigated under various reaction conditions,
using either biphasic systems or monophasic systems
in the presence of significant amount of water miscible
organic cosolvents. Eventually, it was found that the
Scheme 1. Laccase-catalyzed dimerization of substituted phenols.
Scheme 2. Synthesis of chalcones 1a–1c and 2a–2d.
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best performances could be obtained in the presence of
50% v/v acetone. Figure 2 shows the TLC of the
reaction after 6 h.
Usual work up and silica gel chromatography
allowed the isolation of the product(s) corresponding
to the more polar spot at Rf 0.29. Mass spectra analysis
(ESI) indicated the presence of a peak at m/z 447 Da
[M+H+], corresponding to the expected dimeric
product(s) 3, isolated in 26% yield.
However, the 1H NMR spectrum (in CDCl3) clearly
showed that the isolated product was not a pure
compound, and this was confirmed by RP-HPLC,
which indicated the presence of at least two peaks,
although very poorly separated even under the best
chromatographic conditions (Two partially overlapping
peaks were detected, with tR=19.0 min and tR=
19.5 min respectively, using a RP-HPLC analytical
column. For more details see the Experimental part).
Despite that, pure samples corresponding to the two
peaks could be isolated by injecting small amounts of
the mixture of the dimers for several times on a
semipreparative HPLC column carrying the same
stationary phase (for more details see the Experimental
part and Figure 9.1 in Supplementary Materials) and
fully characterized. Both of them (compound C and D)
proved to be dimeric structures by mass spectra
analysis. Figure 3 compares the 1H NMR spectra of the
mixture 3 (top) and of the two isolated compounds C
(middle) and D (bottom) in the range between 5.15 and
7.15 ppm (for the full spectra see supplementary
materials). Diagnostic for C are the two doublets at
5.24 and 6.33 ppm (J=7.2 Hz), whereas for D is the
singlet at 7.08 ppm.
In compound C these signals (obviously together
with all the others present in the spectrum) are
compatible with the structure of the expected dihydro-
benzofuranic dimeric structure, with the two substitu-
ent at C-2 and C-3 position in the trans configuration.
As shown in Scheme 3, this structure is generated (as
previously observed with other vinylic[4] and
stilbenic[5,6] derivatives) by the combination of radical
III and radical II, followed by rearrangement and ring
closure.
On the contrary, combination of radical III and
radical I followed by rearrangement gives two possible
structures that are both compatible with the 1H NMR
spectrum recorded for D (the proton giving a singlet at
7.08 ppm is indicated).
In all our previous investigations, compounds with
structures similar to C have been always isolated as
racemic mixtures of the trans diasteroisomers. Accord-
ingly, HPLC analysis of a sample of C with a chiral
column showed the presence of two equivalent peaks.
Moreover, analysis of the mixture of dimers 3 allowed
the baseline separation both of the two enantiomers 3a
and 3b and of the other isomer (D, from now on
indicated as 3c). As shown in Figure 4, semiprepar-
ative HPLC separation of a new sample of 3 allowed
the separation of the three compounds.
As expected, the samples corresponding to the two
equivalent peaks showed identical NMR spectra and
opposite values of optical rotation power ([α]D=
Figure 2. R: Laccase-catalyzed oxidation of 1a; CLN: substrate
1a; SV: R+CLN
Figure 3. Comparison of a selected portion of the 1H NMR
spectra of 3 (top), C (middle) and D (bottom).
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  163° and [α]D= +163° for Peak 1 and Peak 2,
respectively). Their CD spectra were, as expected,
specular (Figure 5) and, by analogy with previous
literature reports,[5d] allowed us to tentatively assign the
absolute configuration to the stereogenic carbons of
the two enantiomers: 2R,3R for the less retained peak
(3a, Peak 1) and 2S,3S for the more retained one (3b,
Peak 2).
The stereochemistry of the trisubstituted double
bond in 3c was determined measuring the NOEs
involving its vinyl hydrogen. In the NOESY spectrum
the singlet due to this proton shows an obvious contact
with the ortho protons of the p-hydroxyphenylene ring
linked to the same vinyl carbon Cα. In addition a
second clear interaction exists with the ortho protons
of the benzoyl ring linked to Cβ carbon of the double
bond. Instead no interaction was observed with the
other substituent on Cβ, namely the protons ortho to
the oxygen atom of the p-oxyphenylene ring. Taking
advantage of these observations it was possible to
Scheme 3. Laccase-catalyzed dimerization of 4-hydroxy-chalcone 1a.
Figure 4. HPLC chromatogram of the mixture 3 and of the
isolated compounds 3a, 3b, and 3c. Figure 5. Electronic circular dichroism spectra of compounds
3a and 3b.
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conclude that the double bond has the Z stereo-
chemistry where the vinyl proton and the vicinal
benzoyl substituent are cis oriented (Scheme 4).
The same experimental protocol (laccase-catalyzed
oxidation followed by silica gel chromatography) was
applied to the other substituted hydroxychalcones 1b–
1c and 2a–2d, furnishing the expected mixture of
three products (Table 1), as shown by chiral HPLC
(see Supplementary materials). The relative ratio of the
products could be evaluated by comparing the area of
selected signals of the 1H NMR spectra.
Substrates 2a–2d, obtained by the condensation of
vanillin with monosubstituted acetophenones proved to
be more reactive and the reactions needed to be much
more carefully controlled in order to avoid the
predominant formation of complex mixtures of over-
oxidized products.
Finally, to confirm the general scope of the
proposed protocol, the mixtures of dimeric compounds
4, 5, and 9 (obtained by the laccase-catalyzed oxidation
of 1b, 1c, and 2d, respectively) were purified by
preparative HPLC on a chiral column and the
respective products (2R,3R-4a, 2S,3S-4b, 4c; 2R,3R-
5a, 2S,3S-5b, 5c; 2R,3R-9a, 2S,3S-9b, 9c) were
isolated and fully characterized (for more details see
supplementary materials).
In conclusion, the laccase-catalyzed oxidation of 4-
hydroxy-chalcones allowed the isolation of new deriv-
atives possessing the 2,3-dihydrobenzofuran skeleton.
Specifically, the pure enantiomers of the 2,3-disubsti-
tuted trans diasteroisomers could be isolated by semi-
preparative HPLC with a chiral column, following a
protocol previously exploited to purify the oxidized
products obtained from hydroxystilbenes,[5d] The bio-
logical activities of these new compounds, for instance
their ability to act as activators or inhibitors of the
Heat shock protein Hsp90,[6] deserve to be investigated
and the results will be reported in due course.
Experimental Section
General Experimental Procedures
Thin-layer chromarography (TLC): pre-coated glass plates silica
gel 60 with fluorescent indicator UV254. Flash chromatography:
silica gel 60 (70–230 mesh, Merck). HPLC analyses were
carried out using a Prominence Liquid Chromatograph (Shi-
madzu), Kinetex 5 μm EVO C18 100 A LC Column 150×
4.60 mm as achiral analytical column and Lux 5 μm Cellulose-1
Phenomenex 150×4.60 mm as chiral analytical column; Tri
Rotar-VI HPLC, MD-910 multichannel detector (JASCO), Lux
5 μm Cellulose-1 Phenomenex 250×10 mm semi-preparative
column. HPLC condition: isocratic mobile phase water/
acetonitrile (relative ratio and flow rate reported in the
following paragraphs) detection at 400 nm at 25 °C. NMR
spectra (1H and 13C) were recorded on a Bruker AV (400 MHz)
and a Bruker DRX (500 MHz) in CDCl3. Mass spectra were
recorded on a Bruker Esquire 3000 Plus (ESI Ion Trap LC/MSn
System) spectrometer. HRMS spectra were recorded using
electrospray ionization (ESI) technique on a Waters Micromass
Q-Tof micro mass spectrometer. Electronic Circular Dichroism
spectra were recorded on nitrogen flushed Jasco J-1100
spectropolarimeter (Easton MD, USA) interfaced with a
thermostatically controlled cell holder. Electronic Circular
Dichroism analysis was performed with purified compound
dissolved in methanol (0.15 mgmL  1 final concentration for
far-UV analysis, 1 mgmL  1 final concentration for near UV
analysis) in quartz cuvettes with 0.1 cm path length (far-UV
analysis) or 1 cm path length (near-UV analysis). Electronic
Circular Dichroism spectra were recorded in the range between
200 to 400 nm (near-UV analysis) at 20 °C. Optical rotations
were measured on PROPOL Digital Automatic Polarimeter (Dr.
Scheme 4. Structures of compounds 3a, 3b and 3c.
Table 1. Products yields and composition.
Substrate Product,
mg (yield)
Products Relative Ratio[a]
1a (200 mg) 3, 52 mg (26%) 69:31 (3a–b:3c)
1b (785 mg) 4, 135 mg (17%) 81:19 (4a–b:4c)
1c (170 mg) 5, 42 mg (25%) 65:35 (5a–b:5c)
2a (130 mg) 6, 19 mg (15%) 47:53 (6a–b:6c)
2b (150 mg) 7, 24 mg (16%) 58:42 (7a–b:7c)
2c (360 mg) 8, 52 mg (15%) 61:39 (8a–b:8c)
2d (250 mg) 9, 62 mg (25%) 48:52 (9a–b:9c)
[a] Determined by 1H-NMR.
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Kernchen Optik-Elektronik-Automation). The specific rotation
is calculated as follows: a½ �T
l
¼
a 100
cd
. Thereby, the wavelength λ
is reported in nm and the measuring temperature in °C. α
represents the recorded optical rotation, c the concentration of
the analyte in mgmL  1 and d the length of the cuvette in dm.
Thus, the specific rotation is given in 10  1 deg*cm2*g  1. Use of
sodium D line (λ=589 nm) is indicated by D instead of the
wavelength in nm. The sample concentration as well as the
solvent is reported in the relevant section of the experimental
part.
Enzymes and Materials
Laccase from Trametes versicolor (20 Umg  1) was from
Sigma-Aldrich. All other reagents were of the best purity grade
from commercial suppliers.
Synthesis of Chalcones 1a–1c and 2a–2d
General Procedure
a) Basic conditions. A mixture of the required acetophenone
derivative (2.0 mmol) and 4-hydroxybenzaldehyde (2.0 mmol)
was stirred in ethanol (10 mL). To this solution, sodium
hydroxide (6.0 mmol) was added slowly and stirred at room
temperature overnight. The mixture was poured into crushed ice
and acidified with dilute hydrochloric acid. The chalcone
derivative precipitates out as a slightly yellow solid. The desired
product is filtered off and dried to yield the chalcones 1a–1c.
b) Acid conditions. A solution of the required acetophenone
derivative (2.0 mmol) and 4-hydroxybenzaldehyde derivative
(2.0 mmol) in MeOH (6.8 mL) was prepared. H2SO4 (98%,
3.75 mmol, ca 200 μl) was added and the solution was heated to
80 °C for 48 h, monitoring the conversion by TLC (CH2Cl2 –
acetone, 99:1). The solution was neutralized by adding a NaOH
solution (20% w/v). The solution was diluted with water and
extracted with EtOAc. The organic phase was dried (Na2SO4),
the solvent evaporated and the crude residue by silica gel flash
chromatography to yield the chalcones 2a–2d.
(2E)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one (1a)
(yellow solid, 1.38 g, 75% i.y.). Rf=0.45 (eluent petroleum
ether- EtOAc 7:3). MS (ESI): m/z=247.0 Da (M+Na+). 1H
NMR (400 MHz, CDCl3): δ=7.94 (d, J=7.0 Hz, 2H), 7.70 (d,
J=15.6 Hz, 1H), 7.56–7.39 (m, 5H), 7.31 (d, J=15.6 Hz, 1H),
6.84 (d, J=8.6 Hz, 2H), 5.25 (s, 1H). 13C NMR (400 MHz,
CDCl3): δ=190.53, 160.03, 145.19, 138.38, 132.30, 130.29,
128.36, 128.14, 126.03, 118.62, 116.04. The NMR data were in
accordance to the literature values.[15]
(2E)-3-(4-hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-
one (1b) (yellow solid, 784 mg, 80% i.y.). Rf=0.47 (eluent
petroleum ether-EtOAc 7:3). MS (ESI): m/z=498.8 Da (2 M+
Na+). 1H NMR (400 MHz, CDCl3): δ=7.90 (d, J=8.2 Hz, 2H),
7.75 (d, J=15.6 Hz, 1H), 7.51 (d, J=8.6 Hz, 2H), 7.37 (d, J=
15.6 Hz, 1H), 7.28 (d, J=8.0 Hz, 2H), 6.89 (d, J=8.6 Hz, 2H),
2.41 (s, 3H). 13C NMR (400 MHz, CDCl3): δ=190.67, 159.76,
145.17, 143.47, 136.04, 130.53, 129.36, 128.67, 126.78, 119.14,
116.28, 21.71. The NMR data were in accordance to the
literature values.[16]
(2E)-3-(4-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-
one (1c) (yellow solid, 643 mg, 81% i.y.). Rf=0.20 (eluent
petroleum ether-EtOAc 7:3). MS (ESI): m/z=277.0 Da (M+
Na+).1H NMR (400 MHz, CDCl3): δ=9.04 (s, 1 H), 7.97 (d,
J=8.9 Hz, 2 H), 7.70 (d, J=15.5 Hz, 1 H), 7.47 (d, J=8.6 Hz,
2 H), 7.34 (d, J=15.5 Hz, 1 H), 6.93 (d, J=8.9 Hz, 2 H), 6.85
(d, J=8.6 Hz, 2H), 3.84 (s, 3H).13C NMR (400 MHz, CDCl3):
δ=188.41, 162.89, 159.74, 144.03, 131.05, 130.28, 130.00,
126.01, 118.21, 115.85, 113.47, 55.16. The NMR data were in
accordance to the literature values.[17]
(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-phenylprop-2-en-1-
one (2a) (yellow solid, 289 mg, 69% i.y.). Rf=0.52 (eluent
CHCl3-acetone 9:1). MS (ESI): m/z=277.0 Da (M+Na
+). 1H
NMR (400 MHz, CDCl3): δ=8.00 (d, J=7.6 Hz, 2H), 7.75 (d,
J=15.6 Hz, 1H), 7.57 (t, J=7.3 Hz, 1H), 7.50 (t, J=7.6 Hz,
2H), 7.37 (d, J=15.6 Hz, 1H), 7.22 (dd, J=8.2, 1.6 Hz, 1H),
7.14 (s, 1H), 6.96 (d, J=8.2 Hz, 1H), 5.95 (s, 1H), 3.96 (s,
3H).13C NMR (400 MHz, CDCl3): δ=190.83, 148.53, 147.02,
145.40, 138.64, 132.67, 128.68, 128.55, 127.60, 123.51, 119.94,
115.06, 110.23, 56.14. The NMR data were in accordance to the
literature values.[18]
(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-methylphenyl)
prop-2-en-1-one (2b) (yellow solid, 306 mg, 69% i.y.). Rf=
0.30 (eluent CH2Cl2- acetone 99:1). MS (ESI): m/z=291.0 Da
(M+Na+). 1H NMR (400 MHz, CDCl3): δ=7.92 (d, J=
8.2 Hz, 2H), 7.74 (d, J=15.6 Hz, 1H), 7.37 (d, J=15.6 Hz,
1H), 7.30 (d, J=7.9 Hz, 2H), 7.21 (dd, J=8.2, 1.9 Hz, 1H),
7.13 (d, J=1.9 Hz, 1H), 6.95 (d, J=8.2 Hz, 1H), 5.95 (s, 1H),
3.96 (s, 3H), 2.43 (s, 3H). 13C NMR (400 MHz, CDCl3): δ=
190.28, 148.44, 147.00, 144.97, 143.45, 135.91, 129.31, 128.64,
127.57, 123.33, 119.75, 115.03, 110.26, 56.05, 21.67. The NMR
data were in accordance to the literature values.[19]
(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-methoxyphenyl)
prop-2-en-1-one (2c) (yellow solid, 357 mg, 64% i.y.). Rf=
0.23 (eluent petroleum ether-EtOAc 7:3). MS (ESI): m/z=
307.0 Da (M+Na+). 1H NMR (400 MHz, CDCl3): δ=8.03 (d,
J=8.9 Hz, 2H), 7.74 (d, J=15.6 Hz, 1H), 7.39 (d, J=15.6 Hz,
1H), 7.22 (dd, J=8.2, 1.8 Hz, 1H), 7.13 (d, J=1.8 Hz, 1H),
6.98 (d, J=8.9 Hz, 2H), 6.95 (d, J=8.2 Hz, 1H), 5.91 (s, 1H),
3.97 (s, 3H), 3.89 (s, 3H). 13C NMR (400 MHz, CDCl3): δ=
188.95, 163.37, 148.49, 147.13, 144.51, 131.45, 130.79, 127.63,
123.25, 119.55, 115.14, 113.88, 110.34, 56.10, 55.55. The NMR
data were in accordance to the literature values.[18]
(2E)-1-(4-chlorophenyl)-3-(4-hydroxy-3-methoxyphenyl)
prop-2-en-1-one (2d) (yellow solid, 350 mg, 74% i.y.). Rf=
0.38 (eluent CH2Cl2-acetone 99:1). MS (ESI): m/z=311.0 Da
(M+Na+).1H NMR (400 MHz, CDCl3): δ=7.95 (d, J=8.6 Hz,
2H), 7.75 (d, J=15.6 Hz, 1H), 7.47 (d, J=8.6 Hz, 2H), 7.32 (d,
J=15.6 Hz, 1H), 7.22 (dd, J=8.2, 1.9 Hz, 1H), 7.12 (d, J=
1.9 Hz, 1H), 6.96 (d, J=8.2 Hz, 1H), 5.95 (s, 1H), 3.97 (s, 3H).
13C NMR (400 MHz, CDCl3) δ 189.35, 148.69, 147.00, 145.87,
138.99, 136.81, 129.89, 128.90, 127.32, 123.58, 119.14, 115.08,
110.30, 56.07. The NMR data were in accordance to the
literature values.[18]
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Laccase-catalyzed Oxidation of 4-hydroxychalcone
(1a)
A solution of laccase from T. versicolor (8 mL; 2.5 mgmL  1 in
acetate buffer pH 4.5; specific activity: 4.5 Umg  1) was added
to a solution of 4-hydroxychalcone (1a, 200 mg, 0.89 mmol,
with 10 mL of acetate buffer pH 4.5 and 18 mL of acetone).
The reaction mixture was shaken (160 rpm) at 27 °C for 6 h and
monitored by TLC (petroleum ether-EtOAc 7:3). The reaction
was quenched by extraction with EtOAc, and the organic phase
was washed with brine (2×15 mL), dried over Na2SO4 and the
solvent evaporated under reduced pressure. The crude residue
was purified by flash column chromatography (petroleum ether-
EtOAc 7:3) to afford dimeric product(s) as a white foam
(52 mg, 26% yield). Rf=0.29. MS (ESI): C30H23O4 [M+H]
+
447.0 Da.
The dimeric product was submitted to analytical HPLC-UV
analysis using a Kinetex 5 μm EVO C18 100 Å LC Column
150×4.6 mm and a gradient elution (mobile phase: water/
acetonitrile from 50:50 to 20:80; flow rate 0.5 mLmin  1 at 40 °
C; detection at 400 nm). Two peaks were detected: first peak
tR=19.0 min; second peak tR=19.5 min.
The separation of the dimeric products was also carried out by
analytical HPLC-UV analysis using a chiral column (Lux 5 μm
Cellulose-1 Phenomenex, 150×4.60 mm) and an isocratic
elution (mobile phase: water/acetonitrile, 45:55; flow rate
0.5 mLmin  1 at 40 °C; detection at 400 nm). Three peaks were
detected: first peak tR=36.3 min; second peak tR=42.4 min;
third peak tR=46.7 min.
Purification of the Dimeric Products Obtained by
Laccase-catalyzed Oxidation of 4-hydroxychalcone
(1a) by Preparative HPLC
a) With a Reverse-Phase Column
The separation of the two stereoisomers was carried out by
preparative scale HPLC chromatography using a Kinetex 5 μm
EVO C18 100 Å LC Column 150×10.0 mm and a gradient
elution (mobile phase: water/acetonitrile from 80:20 to 20:80;
flow rate 5 mLmin  1 at r.t.; detection at 400 nm). Dimeric
products were dissolved in water/acetonitrile 1:1 at a concen-
tration of 8.5 mgmL  1. The separation protocol was repeated
several time with injection of 0.2 mL of solution in order to
avoid column saturation. In this way, two stereoisomers could
be isolated: compound C and compound D (see Figure 9.1 in
Supplementary Materials).
C: 1H NMR (500 MHz, CDCl3) δ 8.02 (d, J=7.2 Hz, 2H), 7.93
(d, J=7.1 Hz, 2H), 7.69 (t, J=7.4 Hz, 1H), 7.64 (d, J=
15.6 Hz, 1H), 7.59–7.53 (m, 4H), 7.47 (t, J=7.6 Hz, 2H), 7.27
(d, J=8.5 Hz, 2H), 7.22 (d, J=15.6 Hz, 1H), 7.17 (br s, 1H),
6.96 (d, J=8.4 Hz, 1H), 6.84 (d, J=8.6 Hz, 2H), 6.33 (d, J=
7.2 Hz, 1H), 5.24 (d, J=7.2 Hz, 1H). 13C NMR (400 MHz,
CDCl3) δ 195.99, 190.83, 162.02, 156.26, 144.94, 138.55,
136.29, 134.31, 132.77, 132.59, 130.70, 129.39, 129.29, 128.71,
128.55, 128.27, 127.73, 126.55, 125.79, 119.83, 115.93, 110.81,
86.92, 57.94. MS (ESI): 447.0 Da.
D: 1H NMR (500 MHz, CDCl3) δ 7.97 (d, J=7.1 Hz, 2H), 7.85
(d, J=7.0 Hz, 2H), 7.71 (d, J=15.7 Hz, 1H), 7.64 (d, J=
8.7 Hz, 2H), 7.60–7.54 (m, 2H), 7.53 (d, J=8.8 Hz, 2H), 7.48
(t, J=7.6 Hz, 2H), 7.44 (t, J=7.7 Hz, 2H), 7.37 (d, J=
15.7 Hz, 1H), 7.08 (s, 1H), 7.03 (d, J=8.7 Hz, 2H), 6.83 (d,
J=8.8 Hz, 2H). 13C NMR (400 MHz, CDCl3) δ 191.75, 190.78,
158.42, 157.76, 145.97, 144.41, 138.51, 137.41, 132.86, 132.83,
132.62, 130.48, 130.13, 129.72, 129.40, 128.75, 128.61, 128.54,
125.32, 120.92, 116.50, 116.11. MS (ESI): 447.0 Da.
b) With a Chiral-phase Column
The separation of the dimeric products was also carried out by
preparative scale HPLC using a chiral HPLC column (Lux
5 μm Cellulose-1 Phenomenex, 150×4.60 mm) and an isocratic
elution (mobile phase: water/acetonitrile, 45:55; flow rate
5 mLmin  1; detection at 400 nm). Dimeric products were
dissolved in water/acetonitrile 1:1 at a concentration of
8.5 mgmL  1. The first stereoisomer (2R,3R)-3a was eluted
with a retention time of 36.8 min, the second one, (2S,3S)-3b,
at 44.6 min, and the third stereoisomer 3c with a retention time
of 49.2 min. 1H NMR, 13C NMR of (2R,3R)-3a and (2S,3S)-3b
were identical to the above reported data for C.
(2E)-3-[(2R,3R)-3-benzoyl-2-(4-hydroxyphenyl)-2,3-dihydro-
1-benzofuran-5-yl]-1-phenylprop-2-en-1-one [(2R,3R)-3a].
HRMS (ESI): m/z (M  H)  calcd for C30H21O4: 445.1440,
found: 445.1439. [α]D:  163 (c=2.50 ·10
  3 g ·cm  3, CHCl3).
ECD (c=1 mM, MeOH): Δɛ=212 (  2.729), Δɛ=224 (1.894),
Δɛ=261 (  3.280), Δɛ=288 (  1.910), Δɛ=318 (  3.277).
(2E)-3-[(2S,3S)-3-benzoyl-2-(4-hydroxyphenyl)-2,3-dihydro-
1-benzofuran-5-yl]-1-phenylprop-2-en-1-one [(2S,3S)-3b].
[α]D:+163 (c=2.375 ·10
  3 g ·cm  3, CHCl3). ECD (c=1 mM,
MeOH): Δɛ=212 (4.597), Δɛ=225 (  1.203), Δɛ=257
(3.946), Δɛ=290 (1.642), Δɛ=334 (2.722).
(2Z)-3-(4-hydroxyphenyl)-2-{4-[(1E)-3-oxo-3-phenylprop-1-
en-1-yl]phenoxy}-1-phenylprop-2-en-1-one (3c). 1H NMR
and 13C NMR were identical to the above reported data for D.
m/z (M  H)  calcd for C30H22O4 [M  H]
  : 445.1440; found:
445.1441.
Laccase-catalyzed Oxidation of 4-hydroxychalcones
1b–1c and 2a–2d
Enzymatic oxidations were carried out as previously described
and the dimeric products were initially isolated as a mixture by
silica gel chromatography (isolated yields are reported in
Table 1) and then, as an example, some of them were purified
as separated isomers by semi-preparative HPLC using the
previously described chiral column. Specifically:
Laccase-catalyzed Oxidation of 1b
The crude residue was purified by flash column chromatog-
raphy (petroleum ether-EtOAc 7:3) to afford dimeric products
as a white foam (135 mg, Rf=0.30, 17% yield). MS (ESI):
[C32H26O4+H]
+: 475.0. Analysis of the dimeric products was
carried out by analytical HPLC-UV analysis using a chiral
column (Lux 5 μm Cellulose-1 Phenomenex, 150×4.60 mm)
and an isocratic elution (mobile phase: water/acetonitrile,
45:55; flow rate 0.5 mLmin  1 at 40 °C; detection at 400 nm).
Three peaks were detected: first peak tR=60.654 min; second
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peak tR=67.209 min; third peak tR=73.050 min. The separa-
tion of the dimeric products was carried out by preparative scale
HPLC using the chiral column and an isocratic elution (mobile
phase: water/acetonitrile, 45:55; flow rate 5 mLmin  1, detection
at 400 nm). The first stereoisomer (2R,3R)-4a, eluted with a
retention time of 63.4 min, the second one, (2S,3S)-4b, of
71.4 min, and the third stereoisomer 4c with a retention time of
73.7 min. 1H NMR and 13C NMR spectra of (2R,3R)-4a and
(2S,3S)-4b were identical.
(2R,3R)-4a (or (2S,3S)-4b): 1H NMR (400 MHz, CDCl3) δ
7.92 (d, J=8.2 Hz, 2H), 7.85 (d, J=8.2 Hz, 2H), 7.63 (d, J=
15.6 Hz, 1H), 7.56 (dd, J=8.4, 1.6 Hz, 1H), 7.35 (d, J=8.0 Hz,
2H), 7.28–7.27 (m, 2H), 7.26–7.25 (m, 2H), 7.23 (d, J=
15.7 Hz, 1H), 7.17 (s, 1H), 6.95 (d, J=8.4 Hz, 1H), 6.83 (d,
J=8.6 Hz, 2H), 6.33 (d, J=7.2 Hz, 1H), 5.21 (d, J=7.2 Hz,
1H), 2.48 (s, 3H), 2.42 (s, 3H). 13C NMR (400 MHz, CDCl3) δ
195.55, 190.56, 161.99, 156.36, 145.42, 144.78, 143.67, 135.94,
133.79, 132.59, 130.47, 129.97, 129.53, 129.42, 128.73, 128.30,
127.68, 126.74, 125.90, 119.76, 116.41, 115.91, 86.94, 57.80,
21.89, 21.76.
(2E)-3-[(2R,3R)-2-(4-hydroxyphenyl)-3-(4-methylbenzoyl)-
2,3-dihydro-1-benzofuran-5-yl]-1-(4-methylphenyl)prop-2-
en-1-one [(2R,3R)-4a]. m/z (M  H)  calcd for C32H25O4
[M  H]  : 473.1753; found: 473.1745. [α]D:  170.0 (c=
7.2 ·10  3 g ·cm  3, CHCl3). ECD (c=1 mM, MeOH): Δɛ=207
(3.754), 217.4 (  4.061), 226.7 (1.565), 239.3 (  1.117), 249.1
(0.612), 266.9 (  2.002), 291.3 (  1.034), 317.8 (  2.980).
(2E)-3-[(2S,3S)-2-(4-hydroxyphenyl)-3-(4-methylbenzoyl)-
2,3-dihydro-1-benzofuran-5-yl]-1-(4-methylphenyl)prop-2-
en-1-one [(2S,3S)-4b]. [α]D:+169.7 (c=6.0 ·10
  3 g ·cm  3,
CHCl3). ECD (c=1 mM, MeOH): Δɛ=206.8 (  0.590), 216.8
(7.359), 226.9 (0.940), 237.5 (2.829), 249.9 (1.688), 264.7
(3.321), 286.7 (1.898), 337.5 (3.057).
(2Z)-3-(4-hydroxyphenyl)-1-(4-methylphenyl)-2-{4-[(1E)-3-
(4-methylphenyl)-3-oxoprop-1-en-1-yl]phenoxy}prop-2-en-1-
one (4c). 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J=8.2 Hz,
2H), 7.79 (d, J=8.2 Hz, 2H), 7.71 (d, J=15.7 Hz, 1H), 7.64 (d,
J=8.7 Hz, 2H), 7.52 (d, J=8.7 Hz, 2H), 7.37 (d, J=15.6 Hz,
1H), 7.28 (d, J=8.0 Hz, 2H), 7.24 (d, J=8.0 Hz, 2H), 7.05 (d,
J=5.4 Hz, 2H), 7.02 (s, 1H), 6.82 (d, J=8.8 Hz, 2H), 2.43 (s,
3H), 2.41 (s, 3H). 13C NMR (400 MHz, CDCl3) δ 191.39,
190.28, 158.34, 157.47, 146.18, 145.43, 144.52, 144.01, 135.90,
134.57, 132.74, 130.42, 129.65, 129.45, 129.41, 129.25, 128.76,
125.52, 120.89, 116.48, 116.05, 115.89, 21.80. m/z (M  H) 
calcd for C32H25O4 [M  H]
  : 473.1753; found: 473.1757.
Laccase-catalyzed Oxidation of 1c
The crude residue was purified by flash column chromatog-
raphy (petroleum ether-EtOAc 6:4) to afford a dimeric products
as a white foam (42 mg, Rf=0.30, 25% yield). MS (ESI):
[C32H27O6] [M+H]
+: 507.2. The separation of the dimeric
products was carried out by analytical HPLC-UV analysis using
a chiral column (Lux 5 μm Cellulose-1 Phenomenex, 150×
4.60 mm) and an isocratic elution (mobile phase: water/
acetonitrile, 45:55; flow rate 0.5 mLmin  1 at 40 °C; detection at
400 nm). Three peaks were detected: first peak tR=45.588 min;
second peak tR=50.282 min; third peak tR=55.030 min. The
separation of the dimeric products was carried out by
preparative scale HPLC using the chiral column and an isocratic
elution (mobile phase: water/acetonitrile, 45:55; flow rate
5 mLmin  1. The first stereoisomer (2R,3R)-5a, eluted with a
retention time of 45.6 min, the second one, (2S,3S)-5b, at
50.3 min, and the third stereoisomer 5c with a retention time of
52.6 min. 1H NMR and 13C NMR spectra of (2R,3R)-5a and
(2S,3S)-5b were identical.
(2R,3R)-5a (or (2S,3S)-5b): 1H NMR (400 MHz, CDCl3) δ
8.00 (d, J=8.5 Hz, 2H), 7.96 (d, J=8.4 Hz, 2H), 7.64 (d, J=
15.5 Hz, 1H), 7.56 (d, J=8.3 Hz, 1H), 7.26 (s, 1H), 7.26 (d,
J=20.9 Hz, 2H), 7.18 (s, 1H), 7.02 (d, J=8.4 Hz, 2H), 6.97–
6.92 (m, 3H), 6.83 (d, J=8.1 Hz, 2H), 6.32 (d, J=7.2 Hz, 1H),
5.19 (d, J=7.2 Hz, 1H), 3.92 (s, 3H), 3.88 (s, 3H). 13C NMR
(400 MHz, CDCl3) δ 194.39, 189.00, 164.55, 163.48, 161.86,
156.18, 144.12, 132.78, 131.78, 131.45, 130.85, 130.25, 129.22,
128.42, 127.73, 126.92, 125.82, 119.58, 115.89, 114.49, 113.95,
110.70, 87.02, 57.65, 55.79, 55.63.
(2E)-3-[(2R,3R)-2-(4-hydroxyphenyl)-3-(4-methoxybenzoyl)-
2,3-dihydro-1-benzofuran-5-yl]-1-(4-methoxyphenyl)prop-2-
en-1-one [(2R,3R)-5a]. m/z (M  H)  calcd for C32H25O6
[M  H]  : 505.1651; found: 505.1657. [α]D:  164.0 (c=
7.75 ·10  3 g ·cm  3, CHCl3). ECD (c=1 mM, MeOH): Δɛ=210
(4.384), 227 (  4.269), 257 (0.465), 318 (  3.928).
(2E)-3-[(2S,3S)-2-(4-hydroxyphenyl)-3-(4-methoxybenzoyl)-
2,3-dihydro-1-benzofuran-5-yl]-1-(4-methoxyphenyl)prop-2-
en-1-one [(2S,3S)-5b]. [α]D:+164.0 (c=6.25 ·10
  3 g ·cm  3,
CHCl3). ECD (c=1 mM, MeOH): Δɛ=211 (  2.850), 227
(4.479), 257 (  0.165), 316 (4.568).
(2Z)-3-(4-hydroxyphenyl)-1-(4-methoxyphenyl)-2-{4-[(1E)-3-
(4-methoxyphenyl)-3-oxoprop-1-en-1-yl]phenoxy}prop-2-en-
1-one (5c). 1H NMR (500 MHz, CDCl3) δ 7.99 (d, J=8.2 Hz,
2H), 7.91 (d, J=8.2 Hz, 2H), 7.69 (d, J=15.5 Hz, 1H), 7.62 (d,
J=8.0 Hz, 2H), 7.50 (d, J=8.1 Hz, 2H), 7.37 (d, J=15.7 Hz,
1H), 7.02 (d, J=10.9 Hz, 2H), 7.00–6.86 (m, 5H), 6.83 (d, J=
8.0 Hz, 2H), 3.88 (s, 3H), 3.86 (s, 3H). 13C NMR (400 MHz,
CDCl3) δ 190.36, 189.05, 163.57, 163.47, 158.28, 157.86,
146.15, 143.64, 132.65, 131.93, 130.92, 130.37, 129.81, 129.72,
128.68, 125.25, 120.62, 116.46, 116.08, 113.99, 113.97, 113.83,
55.63, 55.60. m/z (M  H)  calcd for C32H25O6 [M  H]
  :
505.1651; found: 505.1655.
Laccase-catalyzed Oxidation of 2d
The crude residue was purified by flash column chromatog-
raphy (petroleum ether-EtOAc 65:35) to afford a dimeric
products as a white foam (62 mg, Rf=0.35, 25% yield). MS
(ESI): [C32H24Cl2O6] [M+Na]
+: 597.3. The separation of the
dimeric products was carried out by analytical HPLC-UV
analysis using a chiral column (Lux 5 μm Cellulose-1 Phenom-
enex, 150×4.60 mm) and an isocratic elution (mobile phase:
water/acetonitrile, 45:55; flow rate 0.5 mLmin  1 at 40 °C;
detection at 400 nm). Three peaks were detected: first peak tR=
82.002 min; second peak tR=86.970 min; third peak tR=
105.240 min. The separation of the dimeric products was
carried out by preparative scale HPLC using the chiral column
(Lux 5 μm Cellulose-1 Phenomenex, 150×4.60 mm) and an
isocratic elution (mobile phase: water/acetonitrile, 45:55; flow
rate 6 mLmin  1, detection at 400 nm). The first stereoisomer
(2R,3R)-9a, eluted with a retention time of 81.8 min, the
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second one, (2S,3S)-9b, eluted with a retention time of
86.5 min, and the third stereoisomer 9c with a retention time of
105.6 min. 1H NMR and 13C NMR spectra of (2R,3R)-9a and
(2S,3S)-9b were identical.
(2R,3R)-9a (or (2S,3S)-9b): 1H NMR (400 MHz, CDCl3) δ
7.94 (d, J=8.6 Hz, 2H), 7.89 (d, J=8.6 Hz, 2H), 7.63 (d, J=
15.6 Hz, 1H), 7.53 (d, J=8.6 Hz, 2H), 7.46 (d, J=8.6 Hz, 2H),
7.26 (s, 1H), 7.18 (d, J=15.5 Hz, 1H), 7.14 (s, 1H), 6.90 (s,
3H), 6.80 (s, 1H), 6.30 (d, J=7.9 Hz, 1H), 5.25 (d, J=7.8 Hz,
1H), 3.97 (s, 3H), 3.87 (s, 3H). 13C NMR (400 MHz, CDCl3) δ
194.79, 189.17, 151.08, 146.94, 146.37, 145.40, 145.26, 141.04,
139.22, 136.81, 134.64, 131.66, 130.69, 129.94, 129.62, 129.05,
129.00, 126.98, 119.56, 119.54, 118.69, 114.88, 112.48, 109.00,
88.12, 58.39, 56.46, 56.21.
(2E)-3-[(2R,3R)-3-(4-chlorobenzoyl)-2-(4-hydroxy-3-methox-
yphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]-1-(4-
chlorophenyl)prop-2-en-1-one [(2R,3R)-9a]. m/z (M  H) 
calcd for C32H23Cl2O6 [M  H]
  : 573.0872; found: 573.0872.
[α]D:  144.0 (c=2.0 ·10
  3 g ·cm  3, CHCl3). ECD (c=1 mM,
MeOH): Δɛ=218.4 (  4.227), 241.9 (0.554), 261.7 (  3.034),
288.7 (  0.771), 327.1 (  1.759).
(2E)-3-[(2S,3S)-3-(4-chlorobenzoyl)-2-(4-hydroxy-3-methox-
yphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]-1-(4-
chlorophenyl)prop-2-en-1-one [(2S,3S)-9b]. [α]D:+144.0
(c=1.5 ·10  3 g ·cm  3, CHCl3). ECD (c=1 mM, MeOH): Δɛ=
219.3 (2.077), 239.1 (  3.40), 269.6 (2.318), 290.9 (  0.168),
354.8 (2.913).
(2Z)-1-(4-chlorophenyl)-2-{4-[(1E)-3-(4-chlorophenyl)-3-oxo-
prop-1-en-1-yl]-2-methoxyphenoxy}-3-(4-hydroxy-3-methox-
yphenyl)prop-2-en-1-one (9c). 1H NMR (400 MHz, CDCl3) δ
7.92 (d, J=8.6 Hz, 2H), 7.84 (d, J=8.6 Hz, 2H), 7.68 (d, J=
15.6 Hz, 1H), 7.46 (d, J=8.4 Hz, 3H), 7.41 (d, J=8.6 Hz, 2H),
7.29 (d, J=15.6 Hz, 1H), 7.22 (dd, J=8.4, 1.9 Hz, 1H), 7.13
(d, J=1.8 Hz, 1H), 7.09 (dd, J=8.3, 1.9 Hz, 1H), 7.01 (s, 1H),
6.90 (d, J=8.3 Hz, 1H), 6.87 (d, J=8.3 Hz, 1H), 3.94 (s, 3H),
3.82 (s, 3H). 13C NMR (400 MHz, CDCl3) δ: 190.00, 189.73,
149.38, 148.00, 147.77, 146.70, 145.90, 145.39, 139.40, 139.04,
136.65, 135.38, 130.89, 130.11, 130.06, 129.73, 129.09, 128.78,
126.08, 125.02, 122.72, 120.61, 115.46, 114.84, 112.49, 112.07,
56.27, 55.87. m/z (M  H)  calcd for C32H23Cl2O6 [M  H]
  :
573.0872; found: 573.0881.
Laccase-catalyzed Oxidation of 2a
The crude residue was purified by flash column chromatog-
raphy (petroleum ether-EtOAc 65:35) to afford dimeric products
as a white foam (19 mg, Rf=0.26, 15% yield). MS (ESI):
[C32H26O6] [M+Na]
+: 529.2. The separation of the dimeric
products 6 was carried out by analytical HPLC-UV analysis
using a chiral column (Lux 5 μm Cellulose-1 Phenomenex,
150×4.60 mm) and an isocratic elution (mobile phase: water/
acetonitrile, 45:55; flow rate 0.5 mLmin  1 at 40 °C; detection at
400 nm). Three peaks were detected: first peak tR=33.417 min;
second peak tR=35.653 min; third peak tR=41.016 min. The
proton NMR of the crude mixture is reported in the Supple-
mentary Materials (S63).
Laccase-catalyzed Oxidation of 2b
The crude residue was purified by flash column chromatog-
raphy (petroleum ether-EtOAc 7:3) to afford dimeric products
as a white foam (24 mg, Rf=0.17, 16% yield). MS (ESI):
[C34H29O6] [M  H]
  : 533.1. The separation of the dimeric
products 7 was carried out by analytical HPLC-UV analysis
using a chiral column (Lux μm Cellulose-1 Phenomenex, 150×
4.60 mm) and an isocratic elution (mobile phase: water/
acetonitrile, 45:55; flow rate 0.5 mLmin  1 at 40 °C; detection at
400 nm). Two peaks were detected: first peak tR=54.556 min;
second peak tR=64.129 min. The proton NMR of the crude
mixture is reported in the Supplementary Materials (S65). As in
the HPLC chromatogram only two peaks were present, these
two peaks were isolated by semipreparative HPLC. Again the
NMR spectra were in accordance with the usual structures 7a/b
and 7c (Supplementary Materials S68 and S71). The circular
dichroism of 7a/b, as expected, confirmed the presence of a
racemic mixture (Supplementary Materials S69).
Laccase-catalyzed Oxidation of 2c
The crude residue was purified by flash column chromatog-
raphy (petroleum ether-EtOAc 5:5) to afford dimeric products
as a white foam (52 mg, Rf=0.43, 15% yield). MS (ESI):
[C34H31O8] [M+H]
+: 567.3. The separation of the dimeric
products 8 was carried out by analytical HPLC-UV analysis
using a chiral column (Lux 5 μm Cellulose-1 Phenomenex,
150×4.60 mm) and an isocratic elution (mobile phase: water/
acetonitrile, 55:45; flow rate 0.4 mLmin  1 at 40 °C; detection at
400 nm). Three peaks were detected: first peak tR=
144.979 min; second peak tR=149.564 min, third peak
180.173 min. The proton NMR of the crude mixture is reported
in the Supplementary Materials (S72).
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